Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CONMED Corporation - Common Stock (NY:CNMD)

57.46 -0.29 (-0.50%)
Streaming Delayed Price Updated: 2:29 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CONMED Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
3 Cash-Producing Stocks Facing Headwinds
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
1 Safe-and-Steady Stock to Consider Right Now and 2 to Be Wary Of
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
The market is filled with gapping stocks in Thursday's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday. 
Via Chartmill
CVS Health Posts Better-Than-Expected Earnings, Joins CommScope, Microsoft, Meta, Chart Industries, And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Earnings Scheduled For April 30, 2025
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Breaking Down Conmed: 6 Analysts Share Their Views
Via Benzinga
CONMED’s (NYSE:CNMD) Q1 Sales Beat Estimates, Stock Soars
Medical tech company CONMED (NYSE:CNMD) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.9% year on year to $321.3 million. The company expects the full year’s... 
Via StockStory
Topics Earnings
Exposures Financial
CONMED Corporation Announces First Quarter 2025 Financial Results
From CONMED Corporation
Via Business Wire
Breaking Down Conmed: 4 Analysts Share Their Views
Via Benzinga
These Analysts Slash Their Forecasts On Conmed After Q4 Results
Via Benzinga
Conmed Q4 Earnings Assessment
Via Benzinga
What To Expect From CONMED’s (CNMD) Q1 Earnings
Medical tech company CONMED (NYSE:CNMD) will be reporting earnings tomorrow after market close. Here’s what you need to know. 
Via StockStory
Topics World Trade
Exposures Tariff
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
3 Reasons to Sell CNMD and 1 Stock to Buy Instead
Over the last six months, CONMED shares have sunk to $51.84, producing a disappointing 19.7% loss - worse than the S&P 500’s 7.3% drop. This was partly driven by its softer quarterly results and may... 
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
CONMED Corporation to Announce First Quarter 2025 Financial Results on April 30, 2025
From CONMED Corporation
Via Business Wire
Insights into Conmed Q4 Earnings
Via Benzinga
Earnings Scheduled For February 5, 2025
Via Benzinga
1 Healthcare Stock with Exciting Potential and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
CONMED CORP (NYSE:CNMD) appears to be flying under the radar despite its strong fundamentals.
CONMED CORP has caught the attention as a great value stock. NYSE:CNMD excels in profitability, solvency, and liquidity, all while being very reasonably priced. 
Via Chartmill
Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX)... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
CONMED Corporation Adds Mark Kaye to its Board of Directors
From CONMED Corporation
Via Business Wire
CONMED Corporation Announces Quarterly Cash Dividend
From CONMED Corporation
Via Business Wire
This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Via Benzinga
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops
Medical tech company CONMED (NYSE:CNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year to $345.9 million. On the other hand, the company’s full-year revenue... 
Via StockStory
CONMED Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results
From CONMED Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.